Silesian University of Medicine   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Katowice Poland (1948)

Organization Overview

First Clinical Trial
2005
NCT01863134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland | Medical School of Silesia | Medical University of Silesia | Medical University of Silesia, Katowice | Silesian Hospital Opava | Silesian Medical University3-Maja 13/15, 41-800 Zabrze; Poland | Silesian University of Medicine

Active Ingredients

Drugs in Phase 4 Trials (15)

acetylsalicylic acid (aspirin) (1 trial)

alteplase (Activase) (1 trial)

carvedilol (coreg) (1 trial)

clopidogrel (plavix) (1 trial)

dabigatran (pradaxa) (1 trial)

eptifibatide (integrilin) (1 trial)

heparin (liquaemin) (1 trial)

lidocaine (xylocaine) (5 trials)

metamizole (Novalgin) (4 trials)

morphine (1 trial)

staloral (1 trial)

ticagrelor (brilinta) (1 trial)

timothy grass pollen allergen extract (Grastek) (1 trial)

valsartan (diovan) (1 trial)

verapamil (calan) (2 trials)

Drugs in Phase 3 Trials (10)

cannabidiol (Epidiolex) (1 trial)

cannabis (1 trial)

dapagliflozin (farxiga) (1 trial)

glimepiride (amaryl) (1 trial)

house dust mite allergen (1 trial)

pioglitazone (actos) (1 trial)

platelet rich plasma (1 trial)

purethal birch (1 trial)

sitagliptin (januvia) (2 trials)

sodium chloride (2 trials)

Drugs in Phase 2 Trials (1)

fish oil (Omegavan) (1 trial)

Drugs in Phase 1 Trials (1)

collagen (1 trial)

Drugs in Other Trials (33)

acetaminophen (tylenol) (4 trials)

atorvastatin (lipitor) (1 trial)

bee venom (1 trial)

bifidobacterium animalis (1 trial)

bifidobacterium bifidum (1 trial)

bupivacaine (Exparel) (1 trial)

cisatracurium (nimbex) (1 trial)

dtap (1 trial)

ephedrine (1 trial)

fenofibrate (fenoglide) (2 trials)

fentanyl (Innovar) (3 trials)

fesoterodine (toviaz) (1 trial)

ketoprofen (orudis) (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus brevis (1 trial)

lactobacillus plantarum (1 trial)

lactobacillus salivarius (1 trial)

lactococcus lactis (1 trial)

levobupivacaine (chirocaine) (3 trials)

midazolam (versed) (1 trial)

ondansetron (zofran) (1 trial)

oxybutynin (ditropan) (1 trial)

oxycodone (oxycontin) (1 trial)

proparacaine (ophthaine) (1 trial)

propofol (diprivan) (2 trials)

remifentanil (ultiva) (3 trials)

ropivacaine (naropin) (2 trials)

sevoflurane (ultane) (1 trial)

solifenacin (vesicare) (1 trial)

tolterodine (detrol) (1 trial)

tramadol (Ultram) (1 trial)

trospium (sanctura) (1 trial)

urapidil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Aneurysm (Phase 4)

Aortic Aneurysm (Phase 4)

Aortic Aneurysm, Abdominal (Phase 4)

Atrial Fibrillation (Phase 4)

Bruxism (Phase 3)

Cardiomyopathies (Phase 4)

Cardiomyopathy, Dilated (Phase 4)

Diabetes Mellitus, Type 2 (Phase 3)

Embolism (Phase 4)

Fatty Liver (Phase 2)

Heart Failure (Phase 4)

Heart Failure, Systolic (Phase 4)

Hypersensitivity (Phase 4)

Infarction (Phase 4)

Liver Diseases (Phase 2)

Marijuana Abuse (Phase 3)

Myalgia (Phase 3)

Myocardial Infarction (Phase 4)

Non-alcoholic Fatty Liver Disease (Phase 2)

Non-ST Elevated Myocardial Infarction (Phase 4)

Pain, Postoperative (Phase 4)

Plaque, Atherosclerotic (Phase 4)

Pulmonary Embolism (Phase 4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Syndrome (Phase 4)

Temporomandibular Joint Disorders (Phase 3)

Temporomandibular Joint Dysfunction Syndrome (Phase 3)

Ventricular Remodeling (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 34
  • # of Trial APIs: 60